# US 2021/0228506 A1 · Ephedrine Compositions and Methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0228506 A1
- Document ID: US20210228506A1
- Status: Published application
- Kind: A1
- Application number: 17/096,822
- Filed: 2020-11-12
- Published: 2021-07-29
- Earliest claimed: 2020-01-22
- Assignees: Nevakar Inc.
- Applicants: Nevakar Inc.
- Inventors: Irfan Ali Mohammed; Tushar Hingorani; Kumaresh Soppimath
- Web page: https://patentgrep.com/patent/US20210228506A1

## CPC

- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 47/02: Inorganic compounds
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed herein are storage-stable ephedrine single-phase solution compositions, comprising 4 mg/mL to 6 mg/mL of ephedrine, a pH adjuster comprising acetic acid, and water, wherein the composition has a pH between 4.5 and 5.0; and wherein the pH drift of the composition is less than 0.5 after storage over at least two months at 25° C. and 60% relative humidity. Also disclosed herein are methods of making and using the same.

## Claims

### Claim 1

A method of preparing a storage-stable, sterile ephedrine ready-to-use solution composition, comprising:
combining in an aqueous solution ephedrine or ephedrine sulfate and sodium chloride to a concentration of about 5 mg/mL ephedrine and about 9 mg/mL sodium chloride;
adjusting a pH of the aqueous solution containing the ephedrine and the sodium chloride to a range of 4.6 to 4.8 to form a pH adjusted ephedrine composition;
wherein the pH is adjusted with a solution containing acetic acid;
wherein a pH drift of the adjusted ephedrine composition is less than 0.5 after storage for 6 months at 25° C. and 60% relative humidity; and
wherein the composition contains about 5% or less total impurities after storage for 6 months at 25 C and 60% relative humidity as determined by HPLC.

### Claim 2 (depends on 1)

The method of claim 1, further comprising a step of sterilizing the pH adjusted ephedrine composition.

### Claim 3 (depends on 2)

The method of claim 2, wherein the step of sterilizing comprises filter sterilization.

### Claim 4 (depends on 2)

The method of claim 2, wherein the step of sterilizing comprises autoclaving.

### Claim 5 (depends on 1)

The method of claim 1, further comprising a step of filling the pH adjusted ephedrine composition into a syringe or vial.

### Claim 6 (depends on 1)

The method of claim 1, further comprising a step of filling the pH adjusted ephedrine composition into a polypropylene syringe.

### Claim 7 (depends on 1)

The method of claim 1, further comprising a step of filling the pH adjusted ephedrine composition into a glass vial.

### Claim 8 (depends on 1)

The method of claim 1, further comprising a step of filling the pH adjusted ephedrine composition into a syringe or vial in an amount of between about 5 mL to about 100 mL.

### Claim 9 (depends on 1)

The method of claim 1, further comprising a step of filling the pH adjusted ephedrine composition into a syringe or vial in an amount of about 1 mL, about 5 mL, about 10 mL, about 20 mL, about 50 mL, or about 100 mL.

### Claim 10 (depends on 1)

The method of claim 1, wherein the adjusted pH of the composition is 4.7.

### Claim 11 (depends on 1)

The method of claim 1, wherein the composition comprises ephedrine sulfate.

### Claim 12 (depends on 1)

The method of claim 1, wherein the composition is substantially free of a preservative.

### Claim 13 (depends on 1)

The method of claim 1, wherein the aqueous solution is water.
